Literature DB >> 10164058

Rational prescribing of antibacterials in ambulatory children.

J E Hoppe1.   

Abstract

The rational prescribing of oral antimicrobial agents for bacterial infections in children who can be treated in an ambulatory setting is the subject of this review. First, restrictive use of antibacterials is advocated to avoid widespread development of bacterial resistance. The use of simple methods, suitable for office use, to discern viral from bacterial infections is recommended. Second, in selecting an antimicrobial agent, the physician should consider a number of distinctive features of each agent. Besides aspects of pharmacokinetics, antibacterial spectrum and tolerability, the number of daily doses and, of particular importance for children, the palatability of suspensions plays an important role in achieving patient compliance. Agents that can be administered once or twice daily and possess an agreeable taste in addition to proven efficacy, established tolerability and a reasonable price are to be preferred. Specific paediatric aspects in choosing among penicillins, cephalosporins, macrolides and other oral antibacterials are discussed. For pharmacoeconomic reasons, the optimal duration of antibacterial treatment and the role of short course therapy for various bacterial infections should be studied in more detail. Finally, rational antimicrobial treatment of common paediatric bacterial infections, such as streptococcal tonsillopharyngitis, acute otitis media, acute sinusitis, bacterial pneumonia, pertussis, Lyme borreliosis (early stage) and lower urinary tract infection is reviewed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 10164058     DOI: 10.2165/00019053-199610060-00004

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  121 in total

Review 1.  Oral cephalosporins.

Authors:  R Wise
Journal:  J Antimicrob Chemother       Date:  1992-02       Impact factor: 5.790

Review 2.  Antimicrobial treatment for urinary tract infections.

Authors:  K Verrier Jones
Journal:  Arch Dis Child       Date:  1990-03       Impact factor: 3.791

3.  The rapid identification of group A beta-hemolytic streptococci in the upper respiratory tract. Current status.

Authors:  E L Kaplan
Journal:  Pediatr Clin North Am       Date:  1988-06       Impact factor: 3.278

Review 4.  Otitis media in children.

Authors:  S Berman
Journal:  N Engl J Med       Date:  1995-06-08       Impact factor: 91.245

Review 5.  Reasons for failures in penicillin treatment of streptococcal tonsillitis and possible alternatives.

Authors:  S E Holm
Journal:  Pediatr Infect Dis J       Date:  1994-01       Impact factor: 2.129

6.  Medication compliance.

Authors:  J T Shope
Journal:  Pediatr Clin North Am       Date:  1981-02       Impact factor: 3.278

Review 7.  Controversies in the use of antimicrobials for the prevention and treatment of Lyme disease.

Authors:  G P Wormser
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

Review 8.  Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-06       Impact factor: 9.546

9.  Pneumonia: antimicrobial therapy for infants and children.

Authors:  D Teele
Journal:  Pediatr Infect Dis       Date:  1985 May-Jun

10.  Single-dose ceftriaxone versus 10 days of cefaclor for otitis media.

Authors:  J M Chamberlain; D A Boenning; Y Waisman; D W Ochsenschlager; B L Klein
Journal:  Clin Pediatr (Phila)       Date:  1994-11       Impact factor: 1.168

View more
  3 in total

1.  Stability, dose uniformity, and palatability of three counterterrorism drugs-human subject and electronic tongue studies.

Authors:  Nakissa Sadrieh; James Brower; Lawrence Yu; William Doub; Arthur Straughn; Stella Machado; Frank Pelsor; Emmanuelle Saint Martin; Terry Moore; John Reepmeyer; Duckhee Toler; Agnes Nguyenpho; Rosemary Roberts; Donald J Schuirmann; Moheb Nasr; Lucinda Buhse
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

Review 2.  Shorter versus longer duration of Amoxicillin-based treatment for pediatric patients with community-acquired pneumonia: a systematic review and meta-analysis.

Authors:  Isabela R Marques; Izabela P Calvi; Sara A Cruz; Luana M F Sanchez; Isis F Baroni; Christi Oommen; Eduardo M H Padrao; Paula C Mari
Journal:  Eur J Pediatr       Date:  2022-09-06       Impact factor: 3.860

Review 3.  Optimizing oral medications for children.

Authors:  Julie A Mennella; Gary K Beauchamp
Journal:  Clin Ther       Date:  2008-11       Impact factor: 3.393

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.